lskbiopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Elevating Outcomes - Elevar |
| Description | A biopharmaceutical company focused on the development of oncology therapeutics and dedicated to elevating treatment experiences and outcomes for patients with limited |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 3.33.152.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
lskbiopharma.com Valuation
|
US$1,194
Last updated: 2022-08-27 10:30:17
lskbiopharma.com has Semrush global rank of 0. lskbiopharma.com has an estimated worth of US$ 1,194, based on its estimated Ads revenue. lskbiopharma.com receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 3.33.152.147. According to SiteAdvisor, lskbiopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,194 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$33 |
| Yearly Ads Revenue | US$396 |
| Daily Unique Visitors | 9 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| lskbiopharma.com. | A | 599 | IP: 3.33.152.147 |
| lskbiopharma.com. | A | 599 | IP: 15.197.142.173 |
| lskbiopharma.com. | NS | 3600 | NS Record: ns33.domaincontrol.com. |
| lskbiopharma.com. | NS | 3600 | NS Record: ns34.domaincontrol.com. |
| lskbiopharma.com. | MX | 3600 | MX Record: 0 lskbiopharma-com.mail.protection.outlook.com. |
| lskbiopharma.com. | TXT | 3600 | TXT Record: MS=ms58008992 |
| lskbiopharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-08-27 10:30:17
| Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Search Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Search Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Elevating Outcomes We take a relentless and inventive approach towards developing and advancing next generation therapies. ELEVAR THERAPEUTICS Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing |
HTTP Headers
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Tue, 21 Dec 2021 11:51:57 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
lskbiopharma.com Whois Information
Domain Name: LSKBIOPHARMA.COM Registry Domain ID: 1671208660_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-08-10T15:54:29Z Creation Date: 2011-08-09T17:27:53Z Registry Expiry Date: 2022-08-09T17:27:53Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:36:34Z <<< |